Endovastec(SH:688016) Sou Hu Cai Jing·2025-06-02 19:50Trading Information Summary - On May 30, 2025, the stock price of Xinmai Medical (688016) closed at 87.94 yuan, down 0.07%, with a turnover rate of 1.06%, trading volume of 13,100 shares, and a transaction amount of 116 million yuan [1] - The capital flow on the same day showed a net inflow of 8.1975 million yuan from main funds, while retail funds experienced a net outflow of 4.7138 million yuan and speculative funds saw a net outflow of 3.4837 million yuan [1][4] Company Announcements Summary - Xinmai Medical adjusted the total cash dividend for the 2024 profit distribution to 42,444,159.80 yuan (including tax), maintaining a cash dividend of 3.5 yuan (including tax) per 10 shares [1][2][4] - The record date for the 2024 annual equity distribution is set for June 5, 2025, with the ex-dividend date and cash dividend payment date on June 6, 2025 [2][4] - The company has adjusted the upper limit of the repurchase price for the second phase of the share buyback plan from 178.35 yuan per share to 178.01 yuan per share, effective from June 6, 2025 [2][4] - China International Capital Corporation conducted a review of the differentiated dividend distribution matters, confirming that shares repurchased into the company's special account do not have profit distribution rights, leading to the implementation of differentiated equity distribution [2]